A vaccine given during late pregnancy can protect newborns from a serious respiratory infection New research shows that immunization for respiratory synctytial virus (RSV) does not increase a woman's risk of preterm birth or other pregnancy complications RSV infection can be deadly in a newborn TUESDAY, July 9, 2024 (HealthDay News) -- Expectant mothers who get vaccinated to protect their newborns against respiratory syncytial virus (RSV) are not putting themselves or their babies at risk, new research affirms. It found that getting the shot during late pregnancy was not associated with increased odds of preterm birth or other outcomes. The difference in preterm birth rates between vaccinated women (5.
9%) and unvaccinated women (6.7%) was not statistically significant, researchers reported July 8 in the journal JAMA Network Open . The finding adds to clinical trial data about the safety of Pfizer's Abrysvo vaccine.
"The real-world evidence provides an additional layer of confidence about the safety of this vaccine during pregnancy," said lead study author Dr. Moeun Son , an associate professor of obstetrics and gynecology at Weill Cornell Medicine in New York City. "We now have data from multiple populations showing no increase in preterm birth risk.
" Up to 80,000 children under age 5 wind up in the hospital nationwide each year with RSV infections , and up to 300 die, according to the U.S. Centers for Disease Control and Prevention.
Based on clinical trial findings, the U.S..
